Diao et al. analyzed NHANES data to show that removing race from eGFR equations would increase the crude prevalence of CKD among Black Americans (14.9% to 18.4% or approximately 1 million individuals). Eligibility for Medicare to cover medical nutrition and CKD education also⬆️.
The authors also reported that removing race could lead to a potential loss of crucial medications (e.g., SGLT2 inhibitors, metformin) and less eligibility for living kidney donation (approximately 16,000 Black individuals).
So are we helping or harming patients when we remove race from equations? Let's review that math🤓🤔. This approach could lead to 1 MILLION Black Americans receiving timely preventative CKD care including aggressive management of blood pressure and diabetes.
We also know that there is an increased risk of death with late referrals to #nephrology. Let's contrast this with the potential and unfortunate loss of lifesaving medications and donor eligibility for several THOUSAND Black Americans. We acknowledge there is a trade-off.
However we strongly believe that ensuring timely and equitable #nephrology care for Black Americans while minimizing harms of inappropriate care underlies the central medical principle of "Do no harm". Harm includes using Black race to dictate care and widen existing disparities.
You can follow @AmakaEMD.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.